慢性胺使用患者的多器官衰竭:一个案例报告
Ayoyimika O Okunlola1, Syahmina Sufrian1, Temitope O Ajao2
1Internal Medicine, United Lincolnshire Hospitals NHS Trust, Lincolnshire, GBR.
Cureus
|December 23, 2024
概括
慢性胺滥用会导致严重的多器官损伤. 这份病例报告详细介绍了一位患者的情况.
科学领域:
- 毒理学 毒理学 毒理学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内部医学 内部医学
背景情况:
- 胺作为一种娱乐性药物越来越普遍.
- 慢性胺滥用与严重的健康风险有关.
- 了解其多器官作用对于临床管理至关重要.
研究的目的:
- 报告慢性胺滥用的多器官功能障碍的情况.
- 描述一个患有严重胺诱导毒性的患者的管理.
- 为了突出目前治疗胺相关器官损伤的局限性.
主要方法:
- 一个24岁的患者的病例报告,有慢性胺滥用的病史.
- 详细评估多器官功能.
- 对患者管理策略的审查.
主要成果:
- 患者呈现出显著的多器官功能障碍.
- 胺戒断是首要的管理步骤.
- 标准治疗只能从胺代谢物的毒性作用中获得有限的缓解.
结论:
- 慢性胺滥用会导致严重和潜在的不可逆转的多器官损伤.
- 对于胺引起的器官损伤的有效治疗方法仍然有限.
- 需要进一步的研究来开发针对胺毒性的向疗法.
相关概念视频
Acute Respiratory Failure-III
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Acute Kidney Injury I: Introduction
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Diabetic Ketoacidosis ll: Pathophysiology
Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...
Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...


